Últimas noticias sobre Getty Images Holdings (NYSE:GETY) Bolsa

Getty Images Holdings

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GETY

SGMO

STNE

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: IHS, HQY, GETY, SGMO y STNE.

5 acciones en el foco este martes: IHS, HQY, GETY, SGMO y STNE

CWCO

SAIC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: SAIC, GETY, CTM, CWCO y TSQ.

5 acciones en el foco este lunes: SAIC, GETY, CTM, CWCO y TSQ

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings Inc

Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GILD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Gilead Sciences. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $436,483, and 4 are calls, amounting to $134,326.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $120.0 for Gilead Sciences over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale trades within a strike price range from $90.0 to $120.0 in the last 30 days. 
<h3>Gilead Sciences 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322647_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$8.35</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$100.00</td>
<td>$249.0K</td>
<td>0</td>
<td align="right">339</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.25</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$120.00</td>
<td>$70.8K</td>
<td>27</td>
<td align="right">50</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.79</td>
<td>$2.67</td>
<td>$2.68</td>
<td>$110.00</td>
<td>$49.7K</td>
<td>2.8K</td>
<td align="right">82</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.97</td>
<td>$1.78</td>
<td>$1.78</td>
<td>$115.00</td>
<td>$40.6K</td>
<td>5.9K</td>
<td align="right">406</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$8.2</td>
<td>$8.0</td>
<td>$8.2</td>
<td>$100.00</td>
<td>$37.7K</td>
<td>0</td>
<td align="right">492</td>
</tr>
</tbody>
</table>

<h3>About Gilead Sciences</h3>
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
In light of the recent options history for Gilead Sciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Gilead Sciences's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,472,451, the GILD's price is up by 0.12%, now at $112.4. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 37 days.</li>
</ul>
<h3>Professional Analyst Ratings for Gilead Sciences</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $129.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Gilead Sciences, which currently sits at a price target of $140. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Gilead Sciences, targeting a price of $126. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Gilead Sciences, maintaining a target price of $130. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Gilead Sciences, which currently sits at a price target of $132. 
&#x2A; In a positive move, an analyst from Deutsche Bank has upgraded their rating to Buy and adjusted the price target to $120. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gilead Sciences with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

GILD

Unpacking the Latest Options Trading Trends in Gilead Sciences

Financial giants have made a conspicuous bearish move on ServiceNow. Our analysis of options history for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) revealed 23 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $1,329,090, and 9 were calls, valued at $478,806.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $600.0 to $1080.0 for ServiceNow during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of ServiceNow stands at 131.59, with a total volume reaching 504.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ServiceNow, situated within the strike price corridor from $600.0 to $1080.0, throughout the last 30 days.
<h3>ServiceNow 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322642_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$52.1</td>
<td>$49.7</td>
<td>$51.1</td>
<td>$740.00</td>
<td>$511.0K</td>
<td align="right">0</td>
<td align="right">100</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$81.7</td>
<td>$77.5</td>
<td>$81.3</td>
<td>$740.00</td>
<td>$333.3K</td>
<td align="right">0</td>
<td align="right">42</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.2</td>
<td>$11.4</td>
<td>$11.4</td>
<td>$1040.00</td>
<td>$114.0K</td>
<td align="right">179</td>
<td align="right">100</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$80.6</td>
<td>$73.2</td>
<td>$77.2</td>
<td>$900.00</td>
<td>$77.2K</td>
<td align="right">716</td>
<td align="right">14</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$69.5</td>
<td>$69.0</td>
<td>$69.0</td>
<td>$830.00</td>
<td>$69.0K</td>
<td align="right">23</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
<h3>ServiceNow's Current Market Status</h3>
<ul>
<li>With a volume of 959,561, the price of NOW is down -1.96% at $826.41. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>Professional Analyst Ratings for ServiceNow</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1144.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on ServiceNow with a target price of $1100. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $1048. 
&#x2A; An analyst from Citizens Capital Markets has revised its rating downward to Market Outperform, adjusting the price target to $1300. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on ServiceNow with a target price of $1000. 
&#x2A; Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for ServiceNow, targeting a price of $1275. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ServiceNow, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on ServiceNow: Analyzing the Surge in Options Activity

On Monday, BofA Securities highlighted its monthly consumer survey of spending expectations, which included around 1,000 respondents in the <a target="_blank" href="https://www.benzinga.com/topic/economic-data" rel="noreferrer noopener">U.S. in March</a>.
The analyst notes an improvement in signs to spend on Home Improvement over the next 3 months, which has increased to 31% vs. 27% last year and has been the highest since May 2024.
Plans to buy a New Home increased slightly from 18% to 20%, but the sentiment is still low compared to the same period in 2021-2023. Plans to have a new baby have improved from 9% to 12% and are flat compared to the 2023 level.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44380787/fda-grants-fast-track-review-to-johnson-johnsons-nipocalimab-for-autoimmune-disorder-that-affects-tears-saliva" rel="noreferrer noopener">FDA Grants Fast Track Review To Johnson &amp; Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva</a>
The&nbsp;Conference Board Consumer Confidence Index&nbsp;fell sharply in February, declining 7.0 points to 98.3, marking the&nbsp;steepest drop&nbsp;since August 2021. This is the third consecutive monthly decline, bringing the index to the lower end <a target="_blank" href="https://www.benzinga.com/news/25/02/43949339/consumer-confidence-plummets-in-february-sharp-decline-marks-third-consecutive-monthly-drop" rel="noreferrer noopener">of its two-year range</a>.
The Conference Board Consumer Confidence Index is a widely watched&nbsp;economic indicator&nbsp;that measures consumer sentiment regarding the current and future state of the economy.
It is based on a monthly survey of 5,000 households, assessing perceptions of business conditions, labor markets and personal finances.
The BofA analyst notes that fewer people noticed more promotions in Electronics this March (8% vs. 10% last year), the lowest since June 2023, marking four months of decline from a peak of 13% in December 2024.
Meanwhile, more respondents say they aren't seeing an increase in discounts overall (48% vs. 42% last year), with this trend rising since November 2024, when it was 40%.
For the next 12 months, upper and lower income respondents see grocery spending increasing. Fifty percent of lower-income respondents expect an increase, the highest level since the survey launched in December 2020.
Earlier this week, the University of Michigan's March consumer confidence survey&nbsp;showed a rapid decrease&nbsp;in consumer confidence amid historically <a target="_blank" href="https://www.benzinga.com/topic/consumer-confidence" rel="noreferrer noopener">high inflation expectations</a>.
The report showed an 11% monthly-over-month drop and a 22% decline from December 2024. Meanwhile, inflation expectations jumped from 4.3% in February to 4.9% in March, the highest reading <a target="_blank" href="https://www.benzinga.com/news/25/03/44344560/horrific-report-economists-warn-consumer-confidence-collapse-signals-economic-trouble" rel="noreferrer noopener">since November 2022</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44380305/whats-going-on-with-tilray-brands-stock-today" target="_blank" rel="noreferrer noopener">Tilray's Manitoba Harvest Rolls Out Superseed Snacks At Whole Foods</a></li>
</ul>
Image via Shutterstock

Analyst Color

Economics

Analyst Ratings

General

Consumer Confidence Dips But Spending On Home Improvements And Family Planning Sees Uptick: Analyst Survey

Investors with a lot of money to spend have taken a bearish stance on Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OXY, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Occidental Petroleum.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 46%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $669,352, and 4 are calls, for a total amount of $254,961.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $37.5 and $65.0 for Occidental Petroleum, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Occidental Petroleum's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Occidental Petroleum's substantial trades, within a strike price spectrum from $37.5 to $65.0 over the preceding 30 days.
<h3>Occidental Petroleum Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322636_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$4.55</td>
<td>$4.4</td>
<td>$4.49</td>
<td>$45.00</td>
<td>$269.4K</td>
<td>264</td>
<td align="right">0</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$50.00</td>
<td>$165.0K</td>
<td>2.4K</td>
<td align="right">500</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$50.00</td>
<td>$101.0K</td>
<td>1.2K</td>
<td align="right">288</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.9</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$50.00</td>
<td>$78.2K</td>
<td>147</td>
<td align="right">2</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.55</td>
<td>$17.4</td>
<td>$17.44</td>
<td>$65.00</td>
<td>$43.6K</td>
<td>525</td>
<td align="right">90</td>
</tr>
</tbody>
</table>

<h3>About Occidental Petroleum</h3>
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.
Following our analysis of the options activities associated with Occidental Petroleum, we pivot to a closer look at the company's own performance.
<h3>Where Is Occidental Petroleum Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,826,662, the price of OXY is up by 0.78%, reaching $47.63.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 49 days from now.</li>
</ul>
<h3>Expert Opinions on Occidental Petroleum</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $54.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Occidental Petroleum, which currently sits at a price target of $52. 
&#x2A; An analyst from UBS persists with their Neutral rating on Occidental Petroleum, maintaining a target price of $56. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Neutral rating on Occidental Petroleum, which currently sits at a price target of $50. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Occidental Petroleum, which currently sits at a price target of $52. 
&#x2A; An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $64. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Occidental Petroleum, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on Occidental Petroleum: Analyzing the Surge in Options Activity

BofA Securities analyst Rafe Jadrosich updated the price forecast for Lennar Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) to reflect the impact of the weak housing market and <a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener">the </a><a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener">Millrose Properties</a><a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener"> spin-off</a>.
The analyst slashed the price forecast to $130 from $140 while retaining a Neutral rating.
Last month, the company completed the spin-off, contributing&nbsp;$5.5 billion&nbsp;in land <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43625476/lennar-completes-spin-off-of-millrose-properties" rel="noreferrer noopener">assets and&nbsp;$1.0 billion in cash</a>.
Jadrosich noted Lennar will pay Millrose an annual option fee of 8.5%, which is expected to be reflected in the cost of goods sold.
The analyst projected a modest net income headwind from Millrose in 2025 (~2%), which was expected to gradually rise to a 6% headwind by 2027 as the land delivered accrued more interest.
Additionally, Jadrosich expected a 30 basis point headwind to gross margin in 2025, with this impact progressively increasing to 85 basis points by 2027.
The analyst wrote Millrose spin-off lowers their tangible book value (TBV) per share forecast by approximately 17%, but it boosts the analyst&#8217;s return on tangible equity (ROTE) forecast by 240bps, 260bps, and 270bps for 2025, 2026, and 2027, respectively.
Meanwhile, Jadrosich expected stronger ROTE tailwinds after 2025 due to the timing of share repurchases.
The analyst projected a $942 million drag on free cash flow (FCF) in 2025 due to the Millrose, which includes a $442 million option payment and a $500 million land deposit related to the spin.
After this initial cash flow headwind, FCF generation is expected to improve with faster inventory turns, added the analyst.
Due to the elevated FCF headwind in 2025, Jadrosich cut the repurchase forecast down to $750 million (from $2.2 billion) but anticipated a significant increase to $2.7 billion in 2026 and $3.0 billion in 2027.
Investors can gain exposure to the stock via iShares U.S. Home Construction ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITB#BATS">ITB</a>) and John Hancock Fundamental All Cap Core ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHAC#NYSE">JHAC</a>).
LEN Price Action: Lennar shares are down 0.33% at $118.57 at publication Tuesday.
Read Next:
 • <a href="https://www.benzinga.com/25/03/44257955/analyst-turns-cautious-on-lennar-lowers-expectations-as-risks-mount-in-housing-sector" target="_blank" rel="noreferrer noopener">Lennar Analyst Moves To Sidelines, Downgrades Stock And Awaits Better Entry Point</a>
Courtesy: Lennar Corp.

Equities

Large Cap

Price Target

Real Estate

iShares Dow Jones US Homenstruction Index Fund

JHAC

BofA Securities Analyst Projects Millrose Spin-Off To Weigh On Lennar's Earnings, Cuts Price Target

On Tuesday, JP Morgan highlighted its survey related to&nbsp;Apellis Pharmaceuticals,&nbsp;Inc.&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) Syfovre and Astellas Pharma Inc&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALPMF#OTC">ALPMF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALPMY#OTC">ALPMY</a>) <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">Izervay</a>.
On average, surveyed physicians treated around 388 geographic atrophy patients and most of them had used Syfovre and Astellas&#8217; Izervay (~80%).
JP Morgan analyst Anupam Rama writes that the survey results point to steadier growth for Syfovre/branded geographic atrophy products over the next 12 months versus an inflection-type growth.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44149348/apellis-lead-drug-pegcetacoplan-represents-differentiated-asset-jp-morgan-analyst" rel="noreferrer noopener">Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst</a>
Survey data indicates that perceptions of Syfovre and Izervay have remained largely unchanged before and after the Izervay CRL and label update. Syfovre is seen as slightly more effective, while Izervay has a safety advantage.
The geographic atrophy market is expected to respond well to promotional efforts. Over time, Apellis&#8217; strategy—including direct-to-consumer marketing, targeting younger physicians, increasing prescribing depth and emphasizing its unique dosing—should drive growth.
The company generated Syfovre sales of $167.8 million and $611.9 million for the fourth quarter and full year 2024, respectively.
It delivered approximately 94,000 Syfovre doses to physician practices in the fourth quarter, including approximately 89,000 commercial vials and 4,600 samples. More than 510,000 Syfovre injections, including clinical trials, are estimated to have been administered since <a href="https://www.benzinga.com/pressreleases/25/02/g44038782/apellis-pharmaceuticals-reports-fourth-quarter-and-full-year-2024-financial-results" target="_blank" rel="noreferrer noopener">launch through December 2024</a>.
Taking a cautious view, the analyst projects a longer timeline for Syfovre to reach peak sales, valuing it along with Empaveli (for PNH) at around the mid-$30s per share—still leaving room for growth from current levels.
JP Morgan maintains an Overweight rating while lowering the <a target="_blank" href="https://www.benzinga.com/quote/APLS/analyst-ratings" rel="noreferrer noopener">price target to $45 from $54</a>, based on extending time to peak and peak sales for Syfovre and adjustments to expenses.
Price Action: APLS stock is down 1.91% at $24.63 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44380592/trump-eyes-approval-of-controversial-steel-merger-nippon-and-us-steel-await-key-decision" target="_blank" rel="noreferrer noopener">Trump Eyes Approval Of Controversial Steel Merger: Nippon, US Steel Await Key Decision</a></li>
</ul>
Photo: Shutterstock

Biotech

Health Care

ALPMF

ALPMY

APLS

JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre

On Tuesday, HC Wainwright initiated coverage on Alpha Cognition Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>), noting a new twist on a tried-and-<a target="_blank" href="https://www.benzinga.com/general/biotech" rel="noreferrer noopener">tested treatment paradigm</a>.
Alpha Cognition&#8217;s lead product, Zunveyl (benzgalantamine), is a prodrug of galantamine—a well-known, long-marketed acetyl cholinesterase inhibitor initially launched in the U.S. by Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) in 2001 under the trade name Reminyl (later changed to Razadyne in 2005).
In July 2024, the FDA approved Zunveyl under the 505(b)(2) pathway.
On Tuesday, Alpha Cognition announced the official commercial launch of Zunveyl, a new treatment for mild to moderate Alzheimer&#8217;s disease.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/42873111/alpha-cognition-inks-44-million-licensing-pact-for-its-alzheimers-drug-in-china" rel="noreferrer noopener">Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer&#8217;s Drug In China</a>
The commercial strategy addresses the challenges of the long-term care market and the largest segment for Alzheimer&#8217;s disease. It&#8217;s also a <a href="https://www.benzinga.com/pressreleases/25/03/b44375080/alpha-cognition-announces-the-commercial-launch-of-zunveyl-benzgalantamine-for-the-treatment-of-mi" target="_blank" rel="noreferrer noopener">$2 billion market opportunity</a>.
Cholinesterase inhibitors (ChEIs) remain the most widely used anti-AD drugs. However, the existing marketed ChEIs are all associated with a significant incidence of gastrointestinal (GI) side effects (e.g., nausea, vomiting, and diarrhea) that typically occur in 30-40% of patients given these drugs.
Existing marketed ChEIs are also associated with a high incidence of sleep disturbances.
HC Wainwright writes the drug will be just as effective as the original molecule while offering better safety and tolerability. Analyst Raghuram Selvaraju estimates Alpha Cognition could reach $540 million in peak annual U.S. sales for Zunveyl by the late 2030s.
HC Wainwright has initiated with a Buy rating with <a target="_blank" href="https://www.benzinga.com/quote/ACOG/analyst-ratings" rel="noreferrer noopener">a price target of $20</a>.
The analyst expects Alpha Cognition to reach cash flow breakeven next year, driven by Zunveyl&#8217;s uptake.
Alpha Cognition&#8217;s share price has not increased in anticipation of the Zunveyl U.S. launch. The company is &#8220;comparatively under-followed,&#8221; Selvaraju wrote.
Alpha Cognition was originally listed on the Canadian Securities Exchange. It voluntarily delisted from that exchange in December 2024 after securing a NASDAQ listing.
Alpha Cognition&#8217;s modest &#8220;sub-$50M enterprise value&#8221; belies the company&#8217;s considerable long-term promise, Selvaraju added. 
The analyst expects Zunveyl uptake and market penetration metrics to drive favorable sentiment going forward.&#8221;
Price Action: ACOG stock is up 3.34% at $5.88 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/03/44380787/fda-grants-fast-track-review-to-johnson-johnsons-nipocalimab-for-autoimmune-disorder-that-affects-tears-saliva" target="_blank" rel="noreferrer noopener">FDA Grants Fast Track Review To Johnson &amp; Johnson&#8217;s Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva</a></li>
</ul>
Image: Shutterstock

Initiation

ACOG

Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst

Financial services provider for shoppers and merchants, Affirm Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) competitor&nbsp;Klarna announced a<a target="_blank" href="https://www.benzinga.com/25/03/44356051/affirm-holdings-stock-is-falling-monday-whats-going-on" rel="noreferrer noopener"> partnership with&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/03/44356051/affirm-holdings-stock-is-falling-monday-whats-going-on" rel="noreferrer noopener">OnePay</a><a target="_blank" href="https://www.benzinga.com/25/03/44356051/affirm-holdings-stock-is-falling-monday-whats-going-on" rel="noreferrer noopener">&nbsp;</a>to offer installment loans at&nbsp;Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>).
The exclusive deal with Walmart means Affirm will no longer provide loan installment services for the retailer. Affirm has been offering installment loan services exclusively to Walmart customers since 2019.
Goldman Sachs analyst Will Nance reiterated a <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings" target="_blank" rel="noreferrer noopener">Buy rating</a> on the shares and raised the price forecast from $50.00 to $56.00 on Monday.
Earlier yesterday, Nance reduced the price forecast for AFRM to $50 from $90. The analyst earlier estimated that Walmart&#8217;s contribution to CY2024 GMV to be roughly ~$2.2 billion (7% of total).
Subsequent to the publishing of the analyst note yesterday morning sizing the impact, Affirm published an 8-K in which the company noted that Walmart comprised 5% of GMV (vs the analyst&#8217;s ~5-10% estimate) and 2% of operating income (vs the analyst&#8217;s 10-19% impact estimate).
The financial impact of Walmart&#8217;s partnership termination on Affirm is now seen as lower than initially expected. This is due to Walmart&#8217;s history with third-party credit providers and the lower profitability of the Walmart partnership.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44372913/whats-going-on-with-nio-stock-today" rel="noreferrer noopener">What&#8217;s Going On With NIO Stock Today?</a>
Affirm&#8217;s lower operating income from this partnership (less than 1% margin) supports this view. The analyst increased price forecast for AFRM in line with the reduced operating income headwind, although still lower than before the announcement, reflecting lower peer multiples and the likely increase in investor sensitivity to competitive intensity.
AFRM recently extended its exclusive partnership with Shopify through 2028, securing a 3-year agreement. Both Shopify and Amazon, AFRM&#8217;s largest partners, hold long-term warrants for AFRM shares, suggesting a deeper, more strategic relationship compared to its previous partnership with Walmart, which was more distant.
AFRM is considered a leading underwriter in the subprime and near-prime credit space, with underwriting capabilities comparable to top incumbents like Capital One.
Its consumer-friendly approach, innovative products, and focus on e-commerce distribution are expected to drive market share gains, per the analyst.
AFRM is poised to benefit from the growth of BNPL in e-commerce, the younger generation&#8217;s preference for installment financing, and BNPL&#8217;s more tailored credit offerings compared to traditional credit cards, the analyst opined.
Walmart has a history of changing credit providers, including ending relationships with Synchrony and Capital One in recent years. This pattern of aggressive partner shifts will likely make investors more cautious about partner concentration risks and competitive pressures in the industry, noted the analyst.
Price Action: AFRM shares traded lower by 9.35% at $43.48 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/03/44359600/hyperfine-nvidia-partner-to-make-brain-mris-more-affordable" target="_blank" rel="noreferrer noopener">Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable</a></li>
</ul>
Image via Shutterstock.

Reiteration

AFRM

How Walmart- Klarna Deal Impacts Affirm? Goldman Sachs Analyst Weighs In

NVDA

NVIDIA Unveils NVIDIA Dynamo Open-Source Inference Software

Investors with a lot of money to spend have taken a bearish stance on Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CVNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 89 uncommon options trades for Carvana.
This isn't normal.
The overall sentiment of these big-money traders is split between 39% bullish and 42%, bearish.
Out of all of the special options we uncovered, 54 are puts, for a total amount of $3,834,395, and 35 are calls, for a total amount of $2,906,489.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $75.0 and $370.0 for Carvana, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Carvana options trades today is 1047.04 with a total volume of 38,583.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Carvana's big money trades within a strike price range of $75.0 to $370.0 over the last 30 days.
<h3>Carvana 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742321755_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$57.9</td>
<td>$55.8</td>
<td>$57.9</td>
<td>$170.00</td>
<td>$445.8K</td>
<td>15</td>
<td align="right">77</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$18.0</td>
<td>$17.7</td>
<td>$17.96</td>
<td>$180.00</td>
<td>$315.5K</td>
<td>2.0K</td>
<td align="right">564</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$25.6</td>
<td>$24.8</td>
<td>$25.6</td>
<td>$175.00</td>
<td>$271.3K</td>
<td>128</td>
<td align="right">270</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.7</td>
<td>$19.3</td>
<td>$19.7</td>
<td>$190.00</td>
<td>$244.2K</td>
<td>96</td>
<td align="right">443</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$94.35</td>
<td>$93.55</td>
<td>$94.3</td>
<td>$260.00</td>
<td>$188.6K</td>
<td>257</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
In light of the recent options history for Carvana, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Carvana</h3>
<ul>
<li>With a trading volume of 3,864,528, the price of CVNA is down by -9.78%, reaching $168.25.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 43 days from now.</li>
</ul>
<h3>What The Experts Say On Carvana</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $309.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from DA Davidson keeps a Neutral rating on Carvana with a target price of $260. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Carvana, which currently sits at a price target of $365. 
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on Carvana, which currently sits at a price target of $320. 
&#x2A; Reflecting concerns, an analyst from Stephens &amp; Co. lowers its rating to Overweight with a new price target of $300. 
&#x2A; An analyst from Stephens &amp; Co. has revised its rating downward to Overweight, adjusting the price target to $300. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Carvana, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

CVNA

What the Options Market Tells Us About Carvana

Investors with a lot of money to spend have taken a bearish stance on Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NET, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Cloudflare.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 66%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $487,657, and 4 are calls, for a total amount of $183,077.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $95.0 to $150.0 for Cloudflare over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cloudflare stands at 538.86, with a total volume reaching 1,012.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cloudflare, situated within the strike price corridor from $95.0 to $150.0, throughout the last 30 days.
<h3>Cloudflare 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742321750_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$26.2</td>
<td>$25.95</td>
<td>$26.2</td>
<td>$110.00</td>
<td>$131.0K</td>
<td>238</td>
<td align="right">0</td>
</tr>
<tr>
<td>NET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$38.4</td>
<td>$36.75</td>
<td>$37.3</td>
<td>$150.00</td>
<td>$119.3K</td>
<td>191</td>
<td align="right">56</td>
</tr>
<tr>
<td>NET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$38.35</td>
<td>$36.85</td>
<td>$37.3</td>
<td>$150.00</td>
<td>$74.6K</td>
<td>191</td>
<td align="right">87</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.2</td>
<td>$150.00</td>
<td>$64.0K</td>
<td>1.6K</td>
<td align="right">202</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$7.35</td>
<td>$7.2</td>
<td>$7.2</td>
<td>$130.00</td>
<td>$51.1K</td>
<td>1.2K</td>
<td align="right">73</td>
</tr>
</tbody>
</table>

<h3>About Cloudflare</h3>
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Having examined the options trading patterns of Cloudflare, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Cloudflare</h3>
<ul>
<li>Trading volume stands at 1,035,050, with NET's price down by -0.46%, positioned at $115.49.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 44 days.</li>
</ul>
<h3>Expert Opinions on Cloudflare</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $154.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Cloudflare, targeting a price of $161. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Cloudflare with a target price of $148. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Cloudflare, targeting a price of $135. 
&#x2A; An analyst from Needham has decided to maintain their Buy rating on Cloudflare, which currently sits at a price target of $145. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $185. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cloudflare, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Smart Money Is Betting Big In NET Options

Deep-pocketed investors have adopted a bearish approach towards Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Sea. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable options, 4 are puts, totaling $185,799, and 4 are calls, amounting to $159,875.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $140.0 for Sea, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Sea's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Sea's substantial trades, within a strike price spectrum from $80.0 to $140.0 over the preceding 30 days.
<h3>Sea Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742321745_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.62</td>
<td>$1.61</td>
<td>$1.61</td>
<td>$110.00</td>
<td>$56.9K</td>
<td>1.4K</td>
<td align="right">355</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.05</td>
<td>$130.00</td>
<td>$53.5K</td>
<td>1.5K</td>
<td align="right">118</td>
</tr>
<tr>
<td>SE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$1.26</td>
<td>$0.86</td>
<td>$1.04</td>
<td>$114.00</td>
<td>$52.0K</td>
<td>7</td>
<td align="right">500</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$5.1</td>
<td>$4.65</td>
<td>$5.0</td>
<td>$130.00</td>
<td>$50.0K</td>
<td>1.5K</td>
<td align="right">218</td>
</tr>
<tr>
<td>SE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$23.55</td>
<td>$23.05</td>
<td>$23.55</td>
<td>$135.00</td>
<td>$44.7K</td>
<td>761</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Sea</h3>
Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid C2C and B2C marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue generating game. Sea's third business, SeaMoney, provides lending, payment, digital banking, and insurance services.As of March 31, 2024, Forrest Xiaodong Li, the founder, chairman and CEO, owned 59.8% of voting power and 18.5% of issued shares. Tencent owned 18.2% of issued shares with no voting power.
<h3>Where Is Sea Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,845,015, with SE's price down by -5.11%, positioned at $125.86.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 56 days.</li>
</ul>
<h3>What The Experts Say On Sea</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $158.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Sea with a target price of $157. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Sea, targeting a price of $160. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Sea, maintaining a target price of $148. 
&#x2A; An analyst from Benchmark persists with their Buy rating on Sea, maintaining a target price of $150. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Sea, which currently sits at a price target of $176. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Sea options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

What the Options Market Tells Us About Sea

As tax season <a href="https://www.benzinga.com/topic/taxes">kicks into high gear</a>, one analyst noted an increase in tax refunds that could leave taxpayers with more cash as they head into spring.
Bank of America analyst Mihir Bhatia analyzed consumer finances as we move into the final weeks of tax season.
Bhatia noted a continued increase in tax refunds by the Internal Revenue Service through 2025. Year-to-date, tax refunds are running 6% higher than they did in 2024, ahead of last year for the third straight week. This year&#8217;s average refund amount is $3,324, up 5.7% from last year.
&#8220;Higher aggregate refunds should be a tailwind for consumers, particularly lower income consumers who use tax refunds for debt paydown and big-ticket purchases,&#8221; the analyst said. &#8220;Total amount refunded running ahead on a y/y basis, well into tax season, is a positive sign for consumer balance sheets.&#8221;
Bhatia said Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>), Bread Financial Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>) and Capital One Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) are the financial services companies &#8220;most exposed to consumers who will utilize tax refunds to pay down debt and for down payments on big-ticket purchases.&#8221; Synchrony and Bread specialize in private-label credit cards at retailers.
Despite President Donald Trump&#8216;s insinuations to cut back on government assistance program funding, the analyst believes government transfer payments will tick up in 2025. This increase will be driven by social security payments rather than relief for younger individuals.
&#8220;We estimate US consumers to receive $70B more in government transfer payments in 2025 vs. 2024, driven by higher social security payments, slightly offset by an increase in student loan payments and lower SNAP payments,&#8221; Bhatia said. &#8220;Overall, while the net impact is more money in the hands of consumers, it appears the benefit would be concentrated among social security recipients, while younger individuals (student loan payments) could face some incremental pressure.&#8221;
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44379453/equity-exposure-plummets-cash-holdings-jump-as-investors-rethink-us-exceptionalism-bank-of-america-survey">Equity Exposure Plummets, Cash Holdings Jump As Investors Rethink &#8216;US Exceptionalism,&#8217; Bank Of America Survey</a></li>
</ul>
Photo: Shutterstock

Personal Finance

Tax Refunds Tick Up In 2025: Synchrony Financial, CapitalOne Affected

Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GTC kicks off today, Mar. 18, and lays the groundwork for another installment of AI and semiconductor-fueled fervor. 
If past is prologue, this could translate to new <a href="https://www.benzinga.com/etfs">momentum for some ETFs</a>.
The following funds have been on a winning streak since the previous GTC, or GPU Technology Conference, took place last March.
Also Read: <a href="https://www.benzinga.com/news/events/25/03/44380519/soundhound-ai-at-2025-nvidia-gpu-technology-conference-in-car-voice-commerce-ecosystem-a-game-changer-for-automotivetech">SoundHound AI At 2025 NVIDIA GPU Technology Conference: In-Car Voice Commerce Ecosystem &#8216;A Game-Changer For #AutomotiveTech&#8217;</a>
<ul>
<li>ProShares UltraShort Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSG#NYSE">SSG</a>) — AUM up 28.3% (according to YCharts), price up 13.33%</li>
</ul>
<ul>
<li>Direxion Daily NVDA Bear 1X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDD#NASDAQ">NVDD</a>) — AUM up 119.9%, price up 8.69%</li>
</ul>
<ul>
<li>Direxion Daily Semiconductor Bear 3x Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXS#NYSE">SOXS</a>) — AUM down 51%, but price up 8.1%</li>
</ul>
The increased AUM indicates that investors have been actively hedging or trading against semiconductor volatility using them. With the buzz on GTC, we may see such trends replicate once all the dust settles after the event.
Also Read: <a href="https://www.benzinga.com/etfs/emerging-market-etfs/25/03/44365756/chinas-ai-surge-fuels-etf-gains-baidu-alibaba-lead-the-way">China&#8217;s AI Surge Fuels ETF Gains: Baidu, Alibaba Lead The Way</a>
Why This Time Could Be Different—Or Not
This year&#8217;s GTC is a big deal not only for Nvidia but also other tech giants like Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), and heavy hitters like Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>). Even quantum computing equities like D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) may experience some aftershocks.
One fascinating aspect is the amount of sessions Nvidia is conducting in Chinese, with some heavy-hitters like Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) Cloud, and ByteDance, according to TechCrunch. Missing from the lineup, however, is DeepSeek, the Chinese AI company that shook Nvidia&#8217;s stock this spring.
DeepSeek&#8217;s meteoric growth resulted in government attention, with reports even suggesting some employees were put under travel bans. The lack of DeepSeek at GTC could reinforce the geopolitical overhang over the AI sector—another influence that could move ETFs in the weeks ahead.
<h2 class="wp-block-heading">What To Watch Post-GTC</h2>
Last GTC revealed Nvidia&#8217;s Blackwell GPUs, and another significant one is likely to come this time. That may portend a new rally in semiconductor ETFs—but also increased volatility.
In addition, with the large Chinese companies showcasing at GTC, investor sentiment regarding U.S.-China AI rivalry may affect ETF performance.
Traders may again mob funds such as NVDD, SSG, and SOXS to bet on both bullish and bearish trends in semiconductors if the last twelve months are anything to go by.
Nvidia&#8217;s GTC has a history of shaping AI and semiconductor markets. Whether it&#8217;s another leg higher or a wave of profit-taking, ETFs that rode last year&#8217;s wave of success could again be the vehicle of choice for traders as they navigate the post-GTC world.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44380264/consumer-spending-stumbles-time-to-buy-the-dip-in-retail-etfs">Consumer Spending Stumbles: Time To Buy The Dip In Retail ETFs?</a></li>
</ul>
Image: Shutterstock

Sector ETFs

ETFs

AVGO

BABA

BIDU

NVDD

QBTS

Direxion Daily Semiconductor Bear 3X Shares

SOXS

3 Best-Performing Semiconductor ETFs Since Last GTC And Why This Time Is Different

During the last three months, 8 analysts shared their evaluations of Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $46.62, a high estimate of $50.00, and a low estimate of $40.00. Surpassing the previous average price target of $46.50, the current average has increased by 0.26%.
<img src="https://www.benzinga.com/files/images/story/2025/1742320866_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Tenable Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hamza Fodderwala</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$45.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Joseph Gallo</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Tenable Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Tenable Holdings compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Tenable Holdings's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Tenable Holdings's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TENB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Tenable Holdings analyst ratings.</a>
<h2>Get to Know Tenable Holdings Better</h2>
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
<h3>Tenable Holdings: Delving into Financials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Tenable Holdings showcased positive performance, achieving a revenue growth rate of 10.51% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Tenable Holdings's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.79%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Tenable Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.46%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Tenable Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.11%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Tenable Holdings's debt-to-equity ratio is below the industry average. With a ratio of 1.05, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TENB

Forecasting The Future: 8 Analyst Projections For Tenable Holdings

During the last three months, 11 analysts shared their evaluations of Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.73, a high estimate of $27.00, and a low estimate of $16.00. A decline of 8.68% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1742320859_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Jamf Holding among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hamza Fodderwala</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Joey Marincek</td>
<td>Citizens Capital Markets</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$27.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$20.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Jamf Holding. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Jamf Holding compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Jamf Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Jamf Holding's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/JAMF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Jamf Holding analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Jamf Holding</h2>
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
<h3>Understanding the Numbers: Jamf Holding's Finances</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Jamf Holding displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 8.18%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -10.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Jamf Holding's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.29% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Jamf Holding's ROA stands out, surpassing industry averages. With an impressive ROA of -1.04%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Jamf Holding's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.52.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JAMF

Deep Dive Into Jamf Holding Stock: Analyst Perspectives (11 Ratings)

In the latest quarter, 4 analysts provided ratings for Jakks Pacific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAKK#NASDAQ">JAKK</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Jakks Pacific and provided 12-month price targets. The average target is $40.0, accompanied by a high estimate of $40.00 and a low estimate of $40.00. The average price target has stayed the same, reflecting a consistent view from analysts. 
<img src="https://www.benzinga.com/files/images/story/2025/1742320851_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Jakks Pacific's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Eric Berg</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Jakks Pacific. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Jakks Pacific compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Jakks Pacific's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Jakks Pacific's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/JAKK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Jakks Pacific analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Jakks Pacific Better</h2>
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
<h3>Breaking Down Jakks Pacific's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Jakks Pacific displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 2.63%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Jakks Pacific's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -6.97% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Jakks Pacific's ROE stands out, surpassing industry averages. With an impressive ROE of -3.72%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Jakks Pacific's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.88% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.24, Jakks Pacific adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JAKK

What Analysts Are Saying About Jakks Pacific Stock

WIIM

WGRX

Wellgistics Health shares are trading higher after the company announced it achieved SOC 2 type 1 compliance.

11 analysts have expressed a variety of opinions on Harmony Biosciences Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Harmony Biosciences Hldgs and provided 12-month price targets. The average target is $58.0, accompanied by a high estimate of $75.00 and a low estimate of $42.00. Experiencing a 3.01% decline, the current average is now lower than the previous average price target of $59.80. 
<img src="https://www.benzinga.com/files/images/story/2025/1742320842_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Harmony Biosciences Hldgs by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$44.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$42.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$50.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>David Hoang</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$52.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Harmony Biosciences Hldgs. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Harmony Biosciences Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Harmony Biosciences Hldgs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Harmony Biosciences Hldgs's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HRMY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Harmony Biosciences Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Harmony Biosciences Hldgs's Background</h2>
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
<h3>A Deep Dive into Harmony Biosciences Hldgs's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Harmony Biosciences Hldgs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 19.51% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Harmony Biosciences Hldgs's net margin excels beyond industry benchmarks, reaching 24.58%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.88%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Harmony Biosciences Hldgs's ROA stands out, surpassing industry averages. With an impressive ROA of 5.13%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.27, Harmony Biosciences Hldgs adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HRMY

Expert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 Analysts

Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $36.08, a high estimate of $41.00, and a low estimate of $28.00. This current average has increased by 5.1% from the previous average price target of $34.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1742320835_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Coterra Energy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Charles Meade</td>
<td>Johnson Rice</td>
<td>Announces</td>
<td>Accumulate</td>
<td>$37.00</td>
<td>-</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$37.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$28.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$33.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Coterra Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coterra Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Coterra Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Coterra Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CTRA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Coterra Energy analyst ratings.</a>
<h2>Discovering Coterra Energy: A Closer Look</h2>
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
<h3>Breaking Down Coterra Energy's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Coterra Energy's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -12.59%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Coterra Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.36%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coterra Energy's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.28%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Coterra Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.43%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.29.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRA

What 13 Analyst Ratings Have To Say About Coterra Energy

Legal

Press Releases

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TURN, DFS, GETY on Behalf of Shareholders

Getty Images and Verizon to Award $20,000 Grant to Champion Disability Representation in the Workplace

Financing

Getty Images Holdings, Inc. Announces Comprehensive Refinancing of Approximately $1.042 Billion Existing Term Loans

Getty Images to Release Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Sports

Getty Images and UEFA Renew Multi-Year Agreement

Getty Images Signs Multi-Year Photography Partnership with the National Women's Soccer League

Getty Images Reports Fourth Quarter and Full Year 2024 Results

CLBR

NARI

NEUE

TURN

VINC

Angi

Bumble

Cars.com

Trump Media & Technology Group Corp. - Warrants

Trump Media & Technology

EverQuote

FuboTV

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

Outbrain

QuinStreet

Shutterstock

Taboola.com

Tripadvisor

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Yelp

Ziff Davis

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

Getty Images Holdings

Noticias

Últimas noticias sobre Getty Images Holdings (NYSE:GETY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL